201 related articles for article (PubMed ID: 9151932)
1. 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists.
Millan MJ; Peglion JL; Lavielle G; Perrin-Monneyron S
Eur J Pharmacol; 1997 Apr; 325(1):9-12. PubMed ID: 9151932
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
Dekeyne A; Girardon S; Millan MJ
Neuropharmacology; 1999 Mar; 38(3):415-23. PubMed ID: 10219979
[TBL] [Abstract][Full Text] [Related]
3. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
Eur J Pharmacol; 2008 Jul; 589(1-3):157-62. PubMed ID: 18582863
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated.
Kennett GA; Trail B; Bright F
Neuropharmacology; 1998 Dec; 37(12):1603-10. PubMed ID: 9886683
[TBL] [Abstract][Full Text] [Related]
5. 8-OH-DPAT-induced spontaneous tail-flicks in the rat are facilitated by the selective serotonin (5-HT)2C agonist, RO 60-0175: blockade of its actions by the novel 5-HT2C receptor antagonist SB 206,553.
Millan MJ; Girardon S; Bervoets K
Neuropharmacology; 1997; 36(4-5):743-5. PubMed ID: 9225301
[TBL] [Abstract][Full Text] [Related]
6. Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents.
Upton N; Stean T; Middlemiss D; Blackburn T; Kennett G
Eur J Pharmacol; 1998 Oct; 359(1):33-40. PubMed ID: 9831290
[TBL] [Abstract][Full Text] [Related]
7. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
[TBL] [Abstract][Full Text] [Related]
8. Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists.
Vickers SP; Easton N; Malcolm CS; Allen NH; Porter RH; Bickerdike MJ; Kennett GA
Pharmacol Biochem Behav; 2001; 69(3-4):643-52. PubMed ID: 11509227
[TBL] [Abstract][Full Text] [Related]
9. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.
Kennett GA; Wood MD; Glen A; Grewal S; Forbes I; Gadre A; Blackburn TP
Br J Pharmacol; 1994 Mar; 111(3):797-802. PubMed ID: 7912626
[TBL] [Abstract][Full Text] [Related]
10. Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats.
Chagraoui A; Protais P; Filloux T; Mocaër E
Psychopharmacology (Berl); 2003 Oct; 170(1):17-22. PubMed ID: 12904965
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.
De Deurwaerdère P; Navailles S; Berg KA; Clarke WP; Spampinato U
J Neurosci; 2004 Mar; 24(13):3235-41. PubMed ID: 15056702
[TBL] [Abstract][Full Text] [Related]
12. Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.
Hewitt KN; Lee MD; Dourish CT; Clifton PG
Pharmacol Biochem Behav; 2002 Apr; 71(4):691-700. PubMed ID: 11888560
[TBL] [Abstract][Full Text] [Related]
13. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo.
Millan MJ; Dekeyne A; Gobert A
Neuropharmacology; 1998 Jul; 37(7):953-5. PubMed ID: 9776391
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist.
Kimura Y; Hatanaka K; Naitou Y; Maeno K; Shimada I; Koakutsu A; Wanibuchi F; Yamaguchi T
Eur J Pharmacol; 2004 Jan; 483(1):37-43. PubMed ID: 14709324
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors.
Millan MJ; Perrin-Monneyron S
Eur J Pharmacol; 1997 Mar; 321(3):R11-3. PubMed ID: 9085055
[TBL] [Abstract][Full Text] [Related]
16. Regulation of septo-hippocampal activity by 5-hydroxytryptamine(2C) receptors.
Hajos M; Hoffmann WE; Weaver RJ
J Pharmacol Exp Ther; 2003 Aug; 306(2):605-15. PubMed ID: 12734389
[TBL] [Abstract][Full Text] [Related]
17. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
[TBL] [Abstract][Full Text] [Related]
18. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
19. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.
Damjanoska KJ; Muma NA; Zhang Y; D'Souza DN; Garcia F; Carrasco GA; Kindel GH; Haskins KA; Shankaran M; Petersen BR; Van De Kar LD
J Pharmacol Exp Ther; 2003 Mar; 304(3):1209-16. PubMed ID: 12604698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
